Sense Biodetection

Abingdon, United Kingdom

Sense Biodetection is a molecular diagnostics company .

$15.0M raised

Nov 2021

Series B

Health Care Health Diagnostics Medical Device

Top Investors

Cambridge Innovation Capital Innovate UK Earlybird Venture Capital Mercia Asset Management Koch Disruptive Technologies

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Sense Biodetection

How much funding has Sense Biodetection raised?

Sense Biodetection has raised $15.0M in total funding. The most recent round was Series B. The last funding was announced in November 2021.

Who are Sense Biodetection's investors?

Sense Biodetection's investors include Cambridge Innovation Capital, Innovate UK, Earlybird Venture Capital, Mercia Asset Management, Koch Disruptive Technologies.

Where is Sense Biodetection headquartered?

Sense Biodetection is headquartered in Abingdon, United Kingdom.

What does Sense Biodetection do?

Sense Biodetection is a molecular diagnostics company .

What stage is Sense Biodetection at?

Sense Biodetection is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 17, 2021.

MLA

"Sense Biodetection — Funding & Investors." VCBacked, November 17, 2021, https://www.vcbacked.co/company/sense-biodetection. Accessed July 1, 2026.

APA

VCBacked. (2021). Sense Biodetection — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/sense-biodetection

Wikipedia (cite web)

{{cite web |title=Sense Biodetection — Funding & Investors |url=https://www.vcbacked.co/company/sense-biodetection |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 17, 2021.